Department of Ophthalmology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunan-Ro, Jongno-Gu, Seoul, 03181, Republic of Korea.
Department of Ophthalmology, The David J. Apple International Laboratory for Ocular Pathology, University of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
BMC Ophthalmol. 2023 Apr 17;23(1):157. doi: 10.1186/s12886-023-02897-2.
To compare the clinical outcomes of bilateral implantation of enhanced intermediate function intraocular lenses (IOLs) and standard monofocal IOLs.
In this prospective, randomized, comparative controlled study, we compared the visual outcomes of patients who underwent bilateral cataract surgery at the Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, with either enhanced monofocal IOLs (Tecnis Eyhance, ICB00, Johnson and Johnson Vision Care, Inc) (Group 1) or standard monofocal IOLs (Tecnis, ZCB00, Johnson and Johnson Vision Care, Inc) (Group 2). The assessment included monocular and binocular uncorrected distance visual acuity (UDVA), uncorrected intermediate (UIVA at 60 cm) and near (UNVA at 40 cm) visual acuity, uncorrected defocus curves, contrast sensitivity testing (CST), and reading speed test using Quality of vision was evaluated using the Visual Function Questionnaire (VFQ-25).
At 3-months postoperatively, monocular and binocular outcomes of UIVA and UNVA were statistically significantly better in Group 1 (P < 0.05). The binocular uncorrected defocus curve of Group 1 showed statistically significantly better outcomes at vergence ranges of -1.5 to -4.0 D (P < 0.05). Significantly higher reading speed test was also observed in Group 1 in all ranges tested (1.0 to 0.1 LogMAR) (P < 0.05). There were no statistically significant differences in CST between groups.
Bilateral implantation of enhanced monofocal IOLs provided better vision at intermediate and near distances compared to standard monofocal IOLs, while maintaining good distance vision and contrast sensitivity.
比较双侧植入增强型中距离功能人工晶状体（IOL）和标准单焦点 IOL 的临床效果。
本前瞻性、随机、对照研究比较了在延世大学三星医疗中心接受双侧白内障手术的患者的视力结果，这些患者植入增强型单焦点 IOL（Tecnis Eyhance，ICB00，Johnson and Johnson Vision Care，Inc）（1 组）或标准单焦点 IOL（Tecnis，ZCB00，Johnson and Johnson Vision Care，Inc）（2 组）。评估包括单眼和双眼未矫正远视力（UDVA）、未矫正中距离（60cm 时的 UIVA）和近视力（40cm 时的 UNVA）、未矫正离焦曲线、对比敏感度测试（CST）和阅读速度测试，使用视觉功能问卷（VFQ-25）评估视力质量。
术后 3 个月，1 组的单眼和双眼 UIVA 和 UNVA 结果在统计学上显著优于 2 组（P<0.05）。1 组的双眼未矫正离焦曲线在 1.5 至-4.0D 的聚散范围内显示出统计学上更好的结果（P<0.05）。在所有测试的范围内（1.0 至 0.1 LogMAR），1 组的阅读速度测试也显著较高（P<0.05）。两组间 CST 无统计学差异。
与标准单焦点 IOL 相比，双侧植入增强型单焦点 IOL 可提供更好的中距离和近距离视力，同时保持良好的远距离视力和对比敏感度。
